Growth factors of russian pharmaceutical companies

The article analyzes the problems of the development of the Russian high-tech business, and pharmaceutical industry in particular. The article discusses and assesses factors affecting the growth of pharmaceutical companies. The sample for the study was compiled based on the SPARK database. In order to identify pharmaceutical companies’ growth factors the production function linking the output with the amount of resources expended was assessed. According to the obtained results, the main growth factors were the factor of labor and current capital, which have the same effect on revenue growth. Research activities that are of particular importance for the pharmaceutical market in the short term have a negative impact on companies’ performance and leads to a decrease in revenue. The results show effective leverage for the operational management of pharmaceutical companies. The proposed methodological approach could also be used for the analysis in other high-tech industries

Keywords: high-tech business, pharmaceuticals, growth factors, production function


  1. Barinova V.A., Bortnik I.M., Zemtsov S.P., Infimovskaya S.Yu., Sorokina A.V. An empirical analysis of the domestic fast growing high-tech companies' competitiveness. Innovatsii [Innovation], 2015, no. 3 (197). pp. 25-31. (in Russ.).
  2. Bekarev A. A., Bekareva S. V. An approach to assessment of competitiveness of national pharmaceutical industry. Vestnik Novosibirskogo Gosudarstvennogo Universiteta. Seriya: sotsial'no-ekonomicheskiye nauki [Vestnik of Novosibirsk State University. Series: Social and Economic Sciences], 2014, Vol. 14, no. 4. pp. 78–91. (in Russ.).
  3. Bekarev A. A., Bekareva S. V. What determine a contemporary state and competitiveness of the Russian pharmaceutical industry. Vestnik Novosibirskogo Gosudarstvennogo Universiteta. Seriya: sotsial'no-ekonomicheskiye nauki [Vestnik of Novosibirsk State University. Series: Social and Economic Sciences], 2015, Vol. 15, no. 1. pp. 23–31. (in Russ.).
  4. Future of work. Korn Ferry, 2017. (in Russ.).
  5. The main resource problem: who will work in Russia? BBC, 2018. (in Russ.).
  6. Zemtsov S.P., Maskaev A.F. Fast-growing firms in Russia: characteristics and growth factors. Innovatsii [Innovation]. 2018, no. 6, pp. 67-75. (in Russ.).
  7. Zemtsov S.P., Chernov A.V. What High-Tech Companies in Russia Grow Faster and Why? Zhurnal Novoy ekonomicheskoy assotsiatsii [The Journal of the New Economic Association]. 2019. no. 1 (41). pp. 68-99. (in Russ.).
  8. Ipatova I. B. The dynamics of total factor productivity and its components: Russian plastic production. Prikladnaya ekonometrika [Applied Econometrics]. 2015, no. 38 (2), pp. 21-40. (in Russ.).
  9. Kolchinskaya E.E., Rastvortseva S.N. Research of the factors of industrial growth in Russia using the production function. Aktual'nyye problemy ekonomiki i prava [Actual problems of economics and law]. 2013, no. 4 (28), pp. 152–158. (in Russ.).
  10. Kravchenko N.A., Kuznetsova S.A., Yusupova A.T. Development of innovative entrepreneurship in regions. Region: ekonomika i sotsiologiya [Region: economy and sociology]. 2011, no. 1, pp. 140-161. (in Russ.).
  11. Labykin A. “Systema” collects pharmacists. Ekspert [Expert]. 2019, no.8, pp. 32-35. (in Russ.).
  12. Mamedyarov Z. Money for new technologies. Ekspert [Expert]. 2019, no. 6, pp.54-57. (in Russ.).
  13. Methodology rating "TechUp". (in Russ.).
  14. Narkevich, IA, Trofimova, E.O., Delvig-Kamenskaya, T.Yu. Challenge of manpower training for the Russian pharmaceutical industry and ways of it overcoming. Innovatsii [Innovation]. 2013, no. 7, P. 3-8. (in Russ.).
  15. Russia in the mirror of international rankings: reference book / executive ed. Suslov, scientific ed. O.V. Valieva, N.A. Kravchenko; IEIE SB RAS. - Novosibirsk: Parallel, 2019. 171 p. (in Russ.).
  16. Russian Pharmaceutical Market Trends in 2017. Track&trace system: additional costs or opportunities? Deloitte CIS Research Centre. Moscow, 2017. 37 p. (in Russ.).
  17. Russian Pharmaceutical Market Trends in 2018. Digital Strategy: building digital bridges to end consumers. Deloitte CIS Research Centre. Moscow, 2018. 42 p. (in Russ.).
  18. Coad A., Rao R. Innovation and firm growth in high-tech sectors: A quantile regression approach//Research Policy. 2008. Vol. 37. P. 633–648.
  19. D’Este P. How do firms’ knowledge bases affect intra-industry heterogeneity?: An analysis of the Spanish pharmaceutical industry//Research Policy. 2005. Vol. 34 (1). P. 33-45.
  20. European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures. Key Data, 2018.
  21. Gagnon M-A, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med.2008;5(1):e1.
  22. Gambardella, A. Science and Innovation in the US Pharmaceutical Industry, Cambridge: Cambridge University Press, 1995.
  23. Geroski P. A., Toker S.. The turnover of market leaders in UK manufacturing industry, 1979-1986//International journal of industrial organization. 1996. Vol. 14 (2). P. 141-158.
  24. Grilli L., Murtinu S. Government, venture capital and the growth of European high-tech entrepreneurial firms//Research Policy. 2014. Vol. 43. P. 1523–1543.
  25. Kravchenko N., Goryushkin A., Ivanova A., Khalimova S., Kuznetsova S., Yusupova A. Determinants of growth of small high-tech companies in transition economies//Model Assisted Statistics and Applications. 2017. Vol. 12 (4). P. 399-412. DOI: 10.3233/MAS-170407
  26. Lexchin J. Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis//Journal of Pharmaceutical Policy and Practice. 2018.
  27. Mazzucato M., Parris S. High growth firms, innovation and competition: the case of the US pharmaceutical industry//SPRU Electronic Working Paper Series, Paper No. SWPS 2013-16, December 2013. 
  28. Olov H. et al. Knowledge spillovers in the supply chain: Evidence from the hightech sectors//Research Policy. 2016. Vol. 45. P. 699–706.
  29. Orsenigo L. The Emergence of Biotechnology, London: Pinter, 1989.
  30. Yusupova A., Kravchenko N. Factors and Perspectives of High Tech Companies’ Growth: Case of Russian Pharmaceutical Sector//GSOM Emerging Markets Conference - 2018 : Conference proceedings. International Research Conf., October, 4-6th, 2018. St. Petersburg, Russia / St. Petersburg State University Graduate School of Management. - St. Petersburg. 2018. P. 284-290.